In this episode, she'll explore the growing demand for the GLP-1 Neck Lift, a procedure designed for patients who've lost significant weight with GLP-1 medications but find their neck still isn't reflecting that progress
Long-acting agents (e.g., dulaglutide, semaglutide, and liraglutide) provide better control of fasting glucose and HbA1c levels
Tucker ME
This reduces production of IL-1, IL-6, TNF-, and other cytokines driving chronic oral inflammation
Researched applications In the published preclinical and clinical literature the effects of AOD-9604 are documented in the following areas: Obesity , Phase 2b failure (2007), but a complementary mechanism in combination protocols Lipolysis in animal models , robustly demonstrated (Heffernan 2001, Ng 2009) Inhibition of lipogenesis , demonstrated in hepatocytes and adipocytes Osteoarthritis and cartilage regeneration , emerging Phase 1/2 data (mLuna Pharmaceuticals 2018+) Tendinopathy , preclinical models Age-related sarcopenia (cachexia) , exploratory plans Lipodystrophy , preclinical data in animal models Hyperlipidemia , secondary endpoints in Phase 2 trials Science & studies 4.1 Key publications Heffernan M., Summers R.J., Thorburn A., et al